Skip to main content

Unlocking the potential of AI in the pharma industry

While drug discovery was an early target for AI capabilities, the technology’s predictive powers have made it a good fit for many other facets of the industry. As pharma leverages real-world uses of AI, the industry has also been careful about big-picture hype for the technology as some of its limitations become clear.

included in this trendline
  • FDA ‘stuck to its corner’ with AI draft guidance, leaving plenty of questions unanswered
  • AlphaFold’s Nobel Prize is ‘the dawn of a new era’ in mapping drug development potential
  • As AI transforms drug development, biotechs might not need as much Big Pharma support
Our Trendlines go deep on the biggest trends. These special reports, produced by our team of award-winning journalists, help business leaders understand how their industries are changing.
Davide Savenije Editor-in-Chief at Industry Dive.